2016 was a great year for the Endocrine Society as we marked our 100-year anniversary with a year-long celebration we dubbed the “Year of Endocrinology.” You may have noticed that throughout 2016 Endocrine News adhered to each of the various months’ themes with at least two articles devoted to the month’s designation. Now that 2017...
Welcome to the 100th year of the Endocrine Society! Endocrine News is going to use every month of 2016 to celebrate this remarkable milestone. First off, there is a year-long editorial calendar that celebrates the “Year of Endocrinology,” and January is devoted to thyroid. To that end, while we will be showcasing some of the...
When an internationally known, often-published, well-respected physician makes the comment that he would rather have HIV than diabetes, controversy is sure to follow. But that’s exactly what Max Pemberton said in his column — entitled, “As a doctor I would rather have HIV than diabetes” — published in the UK magazine The Spectator in 2014. Pemberton admitted that his...
Aside from from the new look of Endocrine News in both print and online, we are now actively involved in the social media realm; we’re tweeting every day from @Endocrine_News, and we plan to engage readers on other platforms as well. So far Twitter has not only proven to be an effective means to get the word out,...
Welcome to the debut of the refreshed Endocrine News! As you thumb through this issue, it will be obvious that there has been a significant design overhaul. We felt this “reboot” vital in order to make Endocrine News a more viable vehicle for how the readers receive information. The goal is to present the content...
Dear Mark – I wanted to take a quick two minutes to thank you for the effort you put in to Endocrine News, and to express my feelings about the excellent content you routinely include. I always read it the day I receive it. I must also point out, however, that when I happily saw...
There’s something about rare disorders that have always intrigued me as a journalist. Granted, they’re not that common so many clinicians don’t necessarily come in contact with them very often. However, it’s that oddity that makes them so interesting and in my mind, makes it so vital that we include them in Endocrine News. In...
This month, we are devoting a considerable amount of space to the topic of clinical trials. This idea was suggested to me last year by Mila Becker, the senior director of Advocacy & Policy Programs for the Endocrine Society. It sounded like a great idea, and it wassomething Endocrine News had never done in the...